This allows for the evaluation of many studies where raw data are unavailable.<h4>Conclusion</h4>PSA seems insufficient for effective prostate cancer screening, despite numerous efforts over decades claiming improvements in sensitivity, specificity, or diagnostic capability. The gene discussed is KLK3; the disease is prostate carcinoma.